Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 1/20 | 0.68 |
| ▸ | TGM2 | P21980 | 1/20 | 0.68 |
| ▸ | KRAS | P01116 | 4/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.63 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.63 |
| ▸ | HINT1 | P49773 | 1/20 | 0.60 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.59 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.59 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.59 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.58 |
| ▸ | IMPDH2 | P12268 | 5/20 | 0.57 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.57 |
| ▸ | GSK3A | P49840 | 2/20 | 0.57 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.57 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Guanosine SCHEMBL19211836 | 1.00 | NT5E (0.68) | NT5ETGM2KRASHPGDFUT5 | |
| Guanosine SCHEMBL30125158 | 1.00 | NT5E (0.68) | NT5ETGM2KRASHPGDFUT5 | |
| Guanosine SCHEMBL6066347 | 0.99 | NT5E (0.69) | NT5ETGM2KRASHPGDFUT5 | |
| Guanosine SCHEMBL9827513 | 0.99 | NT5E (0.69) | NT5ETGM2KRASHPGDFUT5 | |
| Guanosine SCHEMBL30589987 | 0.99 | NT5E (0.69) | NT5ETGM2KRASHPGDFUT5 | |
| Guanosine SCHEMBL37404 | 0.96 | NT5E (0.70) | NT5ETGM2KRASHPGDFUT5 | |
| Guanosine SCHEMBL27797461 | 0.96 | NT5E (0.70) | NT5ETGM2KRASHPGDFUT5 | |
| Guanosine SCHEMBL4410882 | 0.95 | TGM2 (0.65) | NT5ETGM2KRASHPGDFUT5 | |
| Guanosine SCHEMBL22134208 | 0.95 | NT5E (0.69) | NT5ETGM2KRASHPGDFUT5 | |
| Guanosine SCHEMBL29046528 | 0.95 | TGM2 (0.64) | NT5ETGM2KRASHPGDFUT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260021027-A1 | POLYPEPTIDE COSMETIC COMPOSITIONS | ELC MANAGEMENT LLC (US) | 2026-01-22 | — | — | US | claimed |
| CN-119097693-A | Biological peptide antibacterial tablet and preparation method thereof | 广州绿人生物科技有限公司 | 2024-12-10 | — | — | CN | claimed |
| CN-118702745-A | Preparation and application of diguanosine tetraphosphate | 杭州合碳创物科技有限公司 | 2024-09-27 | — | — | CN | claimed |
| CN-115844804-B | Composition for improving exogenous aging and preparation method and application thereof | 湖北省吉美化妆品有限公司 | 2024-07-02 | — | — | CN | claimed |
| EP-4389214-A2 | USE OF TRIMETHOXYBENZYL ACETYLSINAPATE, ADVANTAGEOUSLY IN COMBINATION WITH AT LEAST ONE SUNSCREEN, FOR PROTECTING THE SKIN | Thorel, Jean-Noël (FR) | 2024-06-26 | — | — | EP | claimed |
| EP-3466419-B1 | USE OF TRIMETHOXYBENZYL ACETYLSINAPATE, ADVANTAGEOUSLY IN COMBINATION WITH AT LEAST ONE SUNSCREEN, FOR PROTECTING THE SKIN | THOREL JEAN NOEL (FR) | 2024-05-08 | — | — | EP | claimed |
| CN-116687793-A | Use of myristyl nicotinate in cosmetics | 杭州睿研前瞻生物科技有限公司 | 2023-09-05 | — | — | CN | claimed |
| CN-114795996-B | Composition containing nucleoside components and application thereof | 广东先强药业有限公司 | 2023-08-29 | — | — | CN | claimed |
| CN-115813803-A | Composition capable of improving skin anti-wrinkle, moisturizing and whitening effects on cell layer | 广州时光之城科技有限公司 | 2023-03-21 | — | — | CN | claimed |
| CN-114795996-A | Composition containing nucleoside components and application thereof | 广东先强药业有限公司 | 2022-07-29 | — | — | CN | claimed |
| EP-3142682-B1 | ASSOCIATION OF A TETRAPEPTIDE AND A GLYCERYL ESTER FOR TREATING ANDROGENIC ALOPECIA | FABRE PIERRE DERMO COSMETIQUE (FR) | 2018-11-28 | — | — | EP | claimed |
| EP-1581177-B1 | CUTANEOUS METABOLIC BIO-ACTIVATOR | THOREL JEAN NOEL (FR) | 2018-04-11 | — | — | EP | claimed |
| EP-1480610-B1 | USE OF A HSP INDUCING COMPOUND TO LIMIT SECONDARY EFFECTS OF RETINOIDS | SOC EXTRACTION PRINCIPES ACTIF (FR) | 2008-01-09 | — | — | EP | claimed |
| EP-1025835-B1 | Cosmetic composition for protecting the scalp from free radicals | COTY BV (NL) | 2005-03-23 | — | — | EP | claimed |
| EP-1049455-B1 | COSMETIC PRODUCT BASED ON ARTEMIA SALINA EXTRACTS FOR REGENERATING AND STIMULATING SKIN CELLS | COTY BV (NL) | 2001-08-16 | — | — | EP | claimed |
| EP-1049455-A1 | COSMETIC PRODUCT BASED ON ARTEMIA SALINA EXTRACTS FOR REGENERATING AND STIMULATING SKIN CELLS | Coty B.V. (NL) | 2000-11-08 | — | — | EP | claimed |
| EP-1025835-A2 | Cosmetic composition for protecting the scalp from free radicals | Coty B.V. (NL) | 2000-08-09 | — | — | EP | claimed |
| WO-1999038483-A1 | COSMETIC PRODUCT BASED ON ARTEMIA SALINA EXTRACTS FOR REGENERATING AND STIMULATING SKIN CELLS | COTY B.V. (NL) | 1999-08-05 | — | — | WO | claimed |
| US-20260021027-A1 | POLYPEPTIDE COSMETIC COMPOSITIONS | ELC MANAGEMENT LLC (US) | 2026-01-22 | — | — | US | disclosed |
| WO-1999038483-A1 | COSMETIC PRODUCT BASED ON ARTEMIA SALINA EXTRACTS FOR REGENERATING AND STIMULATING SKIN CELLS | COTY B.V. (NL) | 1999-08-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260021027-A1 | POLYPEPTIDE COSMETIC COMPOSITIONS | CUTA, SPPL2B, SPPL2A | NT5E 308/4885TGM2 177/4885KRAS 4562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.